TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) › Total LiabilitiesTEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) — Total LiabilitiesAnnual figures by period end, from SEC filings.2008-12-31: $16.48B2009-12-31: $13.95B2010-12-31: $16.15B2011-12-31: $27.80B2012-12-31: $27.74B2013-12-31: $24.87B2017-12-31: $51.87B2018-12-31: $44.89B2019-12-31: $42.41B2020-12-31: $39.58B2021-12-31: $36.42B2022-06-30: $36.12B2022-09-30: $34.75B2022-12-31: $35.41B2023-03-31: $34.96B2023-06-30: $35.51B2023-09-30: $34.71B2023-12-31: $35.35B2024-12-31: $33.61B2025-12-31: $32.83B$32.83B2008-12-31Total Liabilities (USD)2025-12-31Period endedTotal LiabilitiesChange YoYSource filing2025-12-31$32.83B-2.3%2026-02-03Balance as of period end2024-12-31$33.61B-4.9%2026-02-03Balance as of period end2023-12-31$35.35B—2025-02-05Balance as of period end2023-09-30$34.71B—2024-02-12Balance as of period end2023-06-30$35.51B—2024-02-12Balance as of period end2023-03-31$34.96B—2024-02-12Balance as of period end2022-12-31$35.41B—2024-02-12Balance as of period end2022-09-30$34.75B—2024-02-12Balance as of period end2022-06-30$36.12B—2024-02-12Balance as of period end2021-12-31$36.42B-8.0%2023-02-10Balance as of period end2020-12-31$39.58B-6.7%2022-02-09Balance as of period end2019-12-31$42.41B-5.5%2021-02-10Balance as of period end2018-12-31$44.89B-13.5%2020-02-21Balance as of period end2017-12-31$51.87B—2019-02-19Balance as of period end2013-12-31$24.87B-10.3%2014-02-10Balance as of period end2012-12-31$27.74B-0.2%2014-02-10Balance as of period end2011-12-31$27.80B+72.1%2013-02-12Balance as of period end2010-12-31$16.15B+15.8%2012-02-17Balance as of period end2009-12-31$13.95B-15.4%2011-02-15Balance as of period end2008-12-31$16.48B—2010-02-22Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)